Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep C Defesche

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Human Genetics : EJHG|September 13, 2012
Low-density lipoprotein receptor mutations generate synthetic genome-wide associationsDaniëlla M Oosterveer, Jorie Versmissen, Joep C Defesche, et al.
Atherosclerosis|September 9, 2008
Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemiaJeroen B van der Net, Jorie Versmissen, Daniëlla M Oosterveer, et al.
European Heart Journal|July 5, 2008
Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemiaJeroen B van der Net, Daniëlla M Oosterveer, Jorie Versmissen, et al.
Circulation. Cardiovascular Genetics|October 20, 2011
Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutationsJorie Versmissen, Daniëlla M Oosterveer, Menno Hoekstra, et al.
European Heart Journal|March 4, 2014
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcomeBarbara Sjouke, D Meeike Kusters, Iris Kindt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Human Mutation|October 13, 2018
ClinVar database of global familial hypercholesterolemia-associated DNA variantsMichael A Iacocca, Joana R Chora, Alain Carrié, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Human Genetics : EJHG|September 13, 2012
Low-density lipoprotein receptor mutations generate synthetic genome-wide associationsDaniëlla M Oosterveer, Jorie Versmissen, Joep C Defesche, et al.
Atherosclerosis|September 9, 2008
Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemiaJeroen B van der Net, Jorie Versmissen, Daniëlla M Oosterveer, et al.
European Heart Journal|July 5, 2008
Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemiaJeroen B van der Net, Daniëlla M Oosterveer, Jorie Versmissen, et al.
Circulation. Cardiovascular Genetics|October 20, 2011
Apolipoprotein isoform E4 does not increase coronary heart disease risk in carriers of low-density lipoprotein receptor mutationsJorie Versmissen, Daniëlla M Oosterveer, Menno Hoekstra, et al.
European Heart Journal|March 4, 2014
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcomeBarbara Sjouke, D Meeike Kusters, Iris Kindt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Human Mutation|October 13, 2018
ClinVar database of global familial hypercholesterolemia-associated DNA variantsMichael A Iacocca, Joana R Chora, Alain Carrié, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
Pageof 10